Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Canada flag Canada · Delayed Price · Currency is CAD
0.970
-0.030 (-3.00%)
Dec 5, 2025, 9:30 AM EST
29.33%
Market Cap 66.82M
Revenue (ttm) 594.57K
Net Income (ttm) -411.84K
Shares Out 68.89M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,682
Average Volume 4,595
Open 0.970
Previous Close 1.000
Day's Range 0.970 - 0.970
52-Week Range 0.295 - 1.100
Beta 0.07
RSI 60.27
Earnings Date Mar 5, 2026

About TSXV:EBM

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. Its licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and g... [Read more]

Founded 2010
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol EBM
Full Company Profile

Financial Performance

In 2024, TSXV:EBM's revenue was 702,076, a decrease of -19.11% compared to the previous year's 867,936. Losses were -455,870, -16.60% less than in 2023.

Financial Statements

News

There is no news available yet.